Nesiritide
- Generic Name
- Nesiritide
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 124584-08-3
- Unique Ingredient Identifier
- P7WI8UL647
- Background
Nesiritide is a medication used to treat acutely decompensated congestive heart failure with dyspnea at rest or with minimal exertion (such as talk, eating or bathing). Nesiritide is a 32 amino acid recombinant human B-type natriuretic peptide.
- Indication
适用于急性代偿性心力衰竭、慢性失代偿性心力衰竭、心肌梗死、心脏导管手术等。由于静脉使用起效快，更适用于急性心力衰竭。
- Associated Conditions
- Acute Decompensated Heart Failure (ADHF)
- Associated Therapies
- -
Effects of Nesiritide in Pediatric Patients With Heart Failure
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2014-06-05
- Lead Sponsor
- Emory University
- Registration Number
- NCT00166010
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
- First Posted Date
- 2005-07-14
- Last Posted Date
- 2013-09-12
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT00119691
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
Phase 3
- Conditions
- First Posted Date
- 2005-05-05
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Ejaz, Abulate A, MD
- Target Recruit Count
- 124
- Registration Number
- NCT00110201
- Locations
- 🇺🇸
Shands Hospital at the University of Florida, Gainesville, Florida, United States
A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure
Phase 2
Completed
- Conditions
- First Posted Date
- 2004-10-01
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Scios, Inc.
- Target Recruit Count
- 920
- Registration Number
- NCT00091520
Use of Nesiritide in the Management of Acute Diastolic Heart Failure
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2004-06-03
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT00083772
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath